Artal International S.C.A. has filed 22 insider transactions across 2 companies since June 2023.
Most recent transaction: a sale of 8000000 shares of CAVA GROUP, INC. ($CAVA) on November 18, 2024.
Activity breakdown: 1 open-market purchase and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2024 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Not found | S | Common Stock | 8000000 | $134.13 | 9,507,990.0000 | 118,430,000 | 45.69% | 6.76% |
| Aug. 26, 2024 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Not found | S | Common Stock | 6000000 | $116.36 | 17,507,990.0000 | 63,448,000 | 25.52% | 9.46% |
| June 5, 2024 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Not found | S | Common Stock | 3000000 | $87.25 | 23,507,990.0000 | 63,448,000 | 11.32% | 4.73% |
| May 10, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Artal International S.C.A. | Not found | M | Common Stock | 57546100 | $0.00 | 175,099,384.0000 | 0 | 48.95% | 0.00% |
| May 10, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Artal International S.C.A. | Not found | M | Series A Convertible Preferred Stock | 1150922 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 10, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Artal International S.C.A. | Not found | A | Series A Convertible Preferred Stock | 1150922 | $108.50 | 1,150,922.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | S | Common Stock | 2000000 | $66.25 | 26,507,990.0000 | 63,448,000 | 7.02% | 3.15% |
| March 13, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Artal International S.C.A. | Not found | A | Series A Convertible Preferred Stock | 1150922 | $108.50 | 1,150,922.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | S | Common Stock | 3500000 | $53.60 | 28,507,990.0000 | 63,448,000 | 10.93% | 5.52% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Series C Preferred Stock | 1845864 | $0.00 | 0.0000 | 1,328,000 | 100.00% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Series D Preferred Stock | 861339 | $0.00 | 0.0000 | 1,328,000 | 100.00% | 64.86% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Series E Preferred Stock | 22252464 | $0.00 | 0.0000 | 1,328,000 | 100.00% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Series F Preferred Stock | 1993092 | $0.00 | 0.0000 | 1,328,000 | 100.00% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Common Stock | 1568865 | $0.00 | 1,568,865.0000 | 1,328,000 | 9999.99% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Common Stock | 3486366 | $0.00 | 5,055,231.0000 | 1,328,000 | 222.22% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Common Stock | 1845864 | $0.00 | 6,901,095.0000 | 1,328,000 | 36.51% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Common Stock | 861339 | $0.00 | 7,762,434.0000 | 1,328,000 | 12.48% | 64.86% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Common Stock | 22252464 | $0.00 | 30,014,898.0000 | 1,328,000 | 286.67% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Common Stock | 1993092 | $0.00 | 32,007,990.0000 | 1,328,000 | 6.64% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Series A Preferred Stock | 1568865 | $0.00 | 0.0000 | 1,328,000 | 100.00% | 100.00% |
| June 20, 2023 | CAVA GROUP, INC. | $CAVA | Artal International S.C.A. | Director | M | Series B Preferred Stock | 3486366 | $0.00 | 0.0000 | 1,328,000 | 100.00% | 100.00% |
| June 5, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Artal International S.C.A. | Director | P | Common Stock | 27775050 | $2.60 | 117,553,284.0000 | 0 | 30.94% | 0.00% |